OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC with contract SPE2DP26F8269 on July 24, 2026, for the delivery of OMEPRAZOLE EXTENDED-RELEASE CAPSULES under delivery order SPE2DX25D9900. The total contract value is $261.60, and the drug is identified by NSN 6505013142716 and PR 7017631918. The award is issued under the Department of Defense, with no specific set-aside type or NAICS code indicated. The place of performance and office address details are not provided, but the contract is managed by the federal agency and accessible through the DIBBS portal. The award notice confirms the transaction as finalized, with no additional point of contact information listed.
General Info
Agency
Contract Value
$261.6NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
